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A paracrine network regulates the cross-talk
between human lung stem cells and the stroma
E. Josue Ruiz1, Feride Oeztuerk-Winder1 & Juan-Jose Ventura1
The signals that regulate stem cell self-renewal and differentiation in the lung remain elusive.
Lung stem cells undergo self-renewal or lineage commitment to replenish tissue, depending
on cross-talk with their environment. This environment, also known as the niche, includes
mesenchymal and endothelial tissues. Here we define molecular mechanisms involved in the
interaction between human lung Lgr6þ stem cells (LSCs) and fibroblasts in a functional
microenvironment. We reveal a central role for p38a MAPK in establishing and maintaining
such cross-talk, acting in both cell types. In LSCs, p38a induces the expression of SDF-1,
which activates the stroma. p38a is essential for fibroblast activation and induction of
cytokine expression, in particular TNFa. This paracrine network induces a hierarchical
activation leading to the recruitment of endothelium, establishing a functional micro-
environment. Disruption of this cross-talk abrogates proper LSC differentiation in vivo and
may lead to lung dysfunction and disease.
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T
he stromal microenvironment plays a fundamental role in
the regulation of tissue homeostasis and the promotion of
pathological processes. The stem cell ‘niche’ allows the
maintenance of multipotency and regulates cell division1. The
niche is a microenvironment that includes the extracellular
matrix, cell contacts and a broad number of autocrine and
paracrine signals and hormones2,3. Altogether, these contributors
regulate the stem cells to either remain in the niche, divide
symmetrically or asymmetrically, or migrate from the niche and
differentiate into either transient progenitors or terminally
differentiated cells4.
In the lung, several niches have been described that harbour
different adult multipotent stem cells involved in the turnover of
distinct anatomical areas of the lung. There are different types of
stem cells in the trachea (submucosal gland stem cell), bronchi
(basal cell) and bronchioles (neuroendocrine bodies)5. Recently, a
group of cells has been reported as putative progenitors for the
mouse bronchioalveolar area, with the potential to differentiate
into Clara or Alveolar (type 1 or 2) cells6.
We previously isolated a population of mouse bronchioalveolar
cells based on negative selection for non-epithelial markers and
sorting for Sca-1/E-Cad-positive cells7. Furthermore, we have
recently characterized a clonally derived population of human
lung Lgr6þ stem cells (LSCs) from the distal lung, which express
E-Cadherin and Lgr6, but not endothelial, mesenchymal or
hematopoietic markers (CD34 /CD73 /CD45 /PECAM ).
The stem cell potential of these cells has been confirmed using
different in vitro and in vivo assays, such as kidney capsule
engraftments and culture of lung explants8. In kidney grafts, LSCs
are able to recapitulate a bronchioalveolar epithelium and also to
recruit connective (Vimentinþ ) and endothelial (CD73þ ) cells
to create a functional environment8.
The role of paracrine signals in the maintenance of stem cell
niches is well known. Activation of stromal cells, and specially
fibroblasts, to induce their migration and production of other
paracrine signals plays an essential role in niche formation
in cancer and homeostasis9,10. Simultaneously, molecular signals
released by the stroma control cell division and fate deter-
mination in stem cells11. Stromal regulation is pivotal for proper
lung homeostasis and the existence of a niche is necessary to
create a functional adult tissue with a turnover potential12.
The balance in cross-talk between signals from the stem cells
and signals from the stroma may also be a determinant for the
proper regeneration of the bronchioalveolar epithelium after
injury13. Failure to maintain the right balance may lead to patho-
logical processes (for example, lung fibrosis, cancer metastasis),
in which inflammatory signalling promotes expansion of the
stromal compartment while preventing epithelial differentiation
and functional tissue repair14.
Here, we delineate how the molecular interactions of a
paracrine signalling circuit of cytokines and chemokines, released
by LSCs and stromal fibroblasts, create a self-maintained
functional microenvironment both in vitro and in vivo. At the
centre of this circuit, acting as intracellular mediators of paracrine
cues in both LSCs and fibroblasts, is the p38a MAPK signalling
pathway. This kinase pathway co-ordinates the release and
response to cytokines in both cell types, and it is necessary for
LSCs to establish and maintain a bronchioalveolar environment
in vivo.
Results
LSCs interact with their environment. We have described a
clonally derived enriched human Lgr6þ population with the
potential to differentiate in vitro and in vivo into all bronch-
ioalveolar mature cell types, named as Lgr6þ stem cells
(LSCs from here on). These cells are able to produce a bronch-
ioalveolar epithelium in an alien environment when injected
under the kidney capsule of nude mice8. This epithelium contains
connective and endothelial tissue (Fig. 1a). Interestingly, we
observed that a discrete population of LSCs is surrounded by
fibroblasts (Vimentinþ ) mimicking a niche, suggesting that
LSCs are able to recruit stromal cells to create their own
microenvironment (Fig. 1a).
Reciprocal modulation between LSCs and fibroblasts. To
functionally test the ability of LSCs to recruit stromal cells, we
used lung slices treated with bleomycin, to remove all kind of
cellular constituents, including bronchiolar, alveolar, mesenchy-
mal and endothelial cell types (Supplementary Fig. 1 and 8). Ex
vivo bleomycin has been used for many years in lung explants as a
model of lung toxicity in vitro15,16. As a DNA-damaging and
ROS-induced apoptotic agent17, it kills most cell types, without
any inflammatory response, producing a physiological scaffold
that allows studying the process followed by LSCs to promote the
recruitment of stromal cells. We injected differentially labelled
LSCs and fibroblasts at different sites to test the range of distance-
dependent paracrine cross-talk. The distance was determined by
monitoring the locations and relative positions of individual LSC
and fibroblast cells over a period of 7 days, allowing us to quantify
the recruitment of fibroblasts to the proximity of LSCs (Fig. 1b–e
and Supplementary Movie 1). Cell tracking was performed for
each cellular type within the region of analysis with an ImageJ
software complemented with a MtrackJ plugin. We observed a
maximum distance of 103 mm for the paracrine signals to engage
LSC recruitment of fibroblasts (Supplementary Fig. 2A), in either
bleomycin-treated or non-treated lung explants (Supplementary
Fig. 2B). The dynamics of the recruitment varies, and it may
depend on paracrine factor gradients around different LSCs
(Fig. 1d,e). Proliferation of LSCs and fibroblasts is promoted only
after they get in close proximity (Fig. 1d, and Supplementary
Fig. 2A). Fibroblasts migrate to LSCs vicinity but do not engage in
direct contact at early time points (Fig. 1d). However, at later
time points LSCs are surrounded by fibroblasts (Fig. 1d and
Supplementary Fig. 2B), recapitulating the kidney graft results
(see Fig. 1a).
Thus, these findings suggest that there is a paracrine cross-talk
between LSCs and fibroblasts inducing the recruitment of the
latter, and recruited fibroblasts enclosing LSCs could function as
putative niche cells.
To begin defining the mechanisms involved in the paracrine
signalling induced as part of the interplay between LSCs and lung
fibroblasts, we used Boyden chambers. A comparative analysis of
the factors released into the medium using a cytokine array
showed a number of changes in the paracrine signal profile
released by LSCs and fibroblasts when cultured either alone or in
close proximity to each other (Fig. 2a, Supplementary Fig. S2C
and Supplementary Table 1 and 2). LSCs co-cultured with
fibroblasts were considered as activated-LSCs (ALSCs). Cytokines
found to be released differentially by ALSCs were involved in the
inflammatory response (TNFa), vascularization (IL8, MIP2) or
chemoattraction (SDF-1) (Fig. 2a and Supplementary Fig. 2C).
These variations in cytokine release were transcriptionally
regulated, as cytokine mRNA expression correlated with protein
levels (Fig. 2b). Especially interesting was the increase in SDF-1
levels induced in ALSCs. This chemokine is essential in
maintaining the hematopoietic stem cell niche, although usually
from mesenchymal or immune cell origin18. Furthermore, in the
co-cultures, activated fibroblasts (AFs) showed an increased in the
expression of both SDF-1 receptors, CXCR4 and CXCR7
(Supplementary Fig. 2D).
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Figure 1 | Analysis of stromal cell recruitment by lung stem cells. (a) LSCs (GFP-labelled) engraft in the kidney capsule and recruit fibroblasts
(Vimentinþ ) and endothelial cells (CD73þ ) (red). Note that fibroblasts surrounded the LSCs. Scale bars: 100mm. (b) General strategy to track the
movement of the cells. Schematic tracing of three pairs of LSC-fibroblasts injected in ex vivo lung tissue from different distances at starting point (arrows).
Relative length graph showing the spatial location of the LSC-fibroblasts injected during a 5-day period. (c) Graphs showing the relative positioning and
schematic tracing of single pairs of LSC-fibroblast cells from different distances at starting point (arrows). (d) Real-time tracing of LSCs (green)
and fibroblasts (red) over a 24 h (upper panel, scale bars: 20mm) or 5 days period (lower panel, scale bars: 200mm). (e) Average of the relative
positioning between injected fibroblasts and LSCs. N¼ 35, from 4–5 experiments±s.e. of the mean s.e.m.
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Figure 2 | SDF-1 released by activated LSCs is the key paracrine factor to recruit stromal fibroblasts. (a) Protein array showing differential cytokine
release by activated LSCs (ALSC) when co-cultured with fibroblasts. (b) The mRNA relative levels of different cytokines confirm their upregulation in
ALSCs. (c) Time-lapse tracing of fibroblast (red) recruitment by LSCs (green) in lung explants. Scale bars, 200mm. (d) Serial sections images captured at
day 4 showing expression of SDF-1 (white) and CXCR4 (purple) by LSCs and fibroblasts, respectively. Scale bars, 50mm. (e) Fibroblast migration induced
by conditioned medium (CM) from ALSCs (expressing control shRNA) (line 4) is prevented by addition of an anti-SDF-1 antibody (line 5) or by using
CM from LSCs lacking SDF-1 (ALSC-KD) (line 6). Addition of SDF-1 recombinant protein into CM from ALSC-KD cells rescued their potential to
recruit fibroblasts (line 7). Scale bar, 200mm. All results (b and e) are the mean±s.e.m. of 4–5 triplicate experiments. Po0.01 values were defined
as statistically significant, as analysed by one-way ANOVA.
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SDF-1 is the key paracrine factor to recruit stromal cells. To
begin defining whether SDF-1 is required for fibroblast recruit-
ment, LSCs and fibroblasts were injected into human lung
explants, and then we analysed the expression of SDF-1 in LSCs
and CXCR4 expression in fibroblasts. Serial sections of the
explants were captured by immunofluorescent microscopy for the
unambiguous identification of both proteins. Importantly and
consistent with the above results, when fibroblasts are recruited
by LSCs (Fig. 2c), the stem cells expressed SDF-1 and the fibro-
blasts expressed the CXCR4 receptor (Fig. 2d).
Using transwell chambers, we also observed that conditioned
medium (CM) from ALSCs induced the migration of fibroblasts
more strongly than CM from LSCs cultured alone (Fig. 2e,
compare lines 2 and 4). Migration was specifically activated,
independently of proliferation, which was not affected. To test
whether SDF-1 released by ALSCs is responsible to induce
fibroblast migration, CM from ALSCs was incubated with a
neutralizing antibody for SDF-1. We found that blocking SDF-1
activity prevented the ability of the ALSCs to induce fibroblast
migration (Fig. 2e, see lines 4 and 5). To confirm this observation,
LSCs expressing short hairpins for SDF-1 (LSC-KD) were
generated (Supplementary Fig. 2E) and the CM from either
LSC-KD cultured alone or co-cultured with fibroblasts (ALSC-
KD) was used as a chemoattractant. As expected, knocking
down SDF-1 in ALSCs (Supplementary Fig. 2F) also inhibited
fibroblast migration (Fig. 2e, see lines 4 and 6). Finally,
confirmation of the chemoattractant role of SDF-1 was shown
by rescuing recruitment of fibroblasts by the addition of
recombinant SDF-1 protein to the CM from ALSC-KD (Fig. 2e,
see lines 4, 6 and 7).
On the basis of this evidence, we hypothesized that the
inhibition of SDF-1 would result in the impairment of fibroblast
migration in lung explants. To test this hypothesis, we injected
fibroblasts together with either LSCs expressing a short hairpin
control or LSC-KD into human lung explants. In agreement with
previous results, LSCs expressing a shControl were able to recruit
fibroblasts (Fig. 3a). However, the injection of LSCs lacking SDF-
1 expression confirmed the absence of the necessary paracrine
cross-talk to recruit fibroblasts via SDF-1 (Fig. 3a, middle panel,
and Supplementary Fig. 3A, B). Fibroblasts recruitment could
be rescued by overexpression of a SDF-1 mRNA resistant to
shSDF-1 knockdown or embedding SDF-1 protein in the
matrigel carrying the LSC-KD cells (Fig. 3a, right panel, and
Supplementary Fig. 3C,D). Furthermore and consistent with the
above results, recruited fibroblasts are able to enclose LSCs.
Finally, kidney capsule engraftments were used to test, in vivo,
the observed in vitro role of SDF-1 in the recruitment of stromal
fibroblasts. We found that LSCs lacking SDF-1 (LSC-KD)
failed to produce grafts under the kidney capsule (Fig. 3b and
Supplementary Fig. 3E). However, again it could be rescued
by overexpression of shSDF-1 resistant mRNA (Fig. 3b and
Supplementary Table 3) or embedding SDF-1 recombinant
protein in the matrigel carrying the LSC-KD cells
(Supplementary Fig. 3E,F). The inability of the LSC-KD cells to
engraft was independent of their proliferative potential
(Supplementary Fig. 3G). Interestingly, the engraftments showed
that LSC-KD cells, rescued by shSDF-1 resistant mRNA, were
able to recruit stromal cells from the host tissue (Fig. 3c).
Furthermore, we also found that a small population of LSCs was
surrounded by fibroblasts (Vimentinþ ) or endothelial cells
(CD73þ ) recapitulating a niche (Fig. 3c). The mouse origin of
the stroma in the graft was confirmed as it did not express GFP
and was negative for an anti-human mitochondrial antibody
(Supplementary Fig. 3H).
Together, these data suggest that SDF-1 released by LSCs has
an essential role in the recruitment of stromal cells.
Regulation of SDF-1 expression and secretion by TNFa and
TGFb. Having demonstrated the essential role of SDF-1 to recruit
stromal cells, we next sought to understand how SDF-1 expres-
sion is regulated by stromal fibroblasts. It has been reported that,
depending on cellular context, either TGFb or TNFa signalling
pathways can regulate SDF-1 expression19,20. Thus, SDF-1
regulation in LSCs by TNFa and TGFb pathways was tested.
Although TNFa was able to induce SDF-1 expression, TGFb was
a much stronger activator in LSCs (Fig. 4a). Interestingly, TGFb
levels were increased in ALSCs (Fig. 4b), but not in AFs
(Supplementary Fig. 4A), so TGFb was excluded as the putative
paracrine signal used by the fibroblasts to promote SDF-1
expression in LSCs. Nevertheless, AFs expressed and released
more TNFa (Fig. 4g, upper panel, and Supplementary Fig. 4B).
This cytokine was considered as a candidate to induce the
paracrine activation of LSCs. As TGFb was not of fibroblastic
origin, a possible autocrine regulation of SDF-1 expression in
ALSCs was considered. To test this possibility, ALSCs were
incubated with a neutralizing antibody for TGFb. We found that
blocking TGFb activity inhibited the ability of the ALSCs to
express SDF-1, confirming the autocrine role of TGFb
(Supplementary Fig. 4C).
TGFb expression can be induced by TNFa through c-Jun
activation21. Indeed, LSCs responded to exogenous TNFa
treatment by activating the JNK/AP-1 pathway (Supplementary
Fig. 4D). In addition, we observed a correlation between TNFa-
induced TGFb and SDF-1 expression in LSCs (Supplementary
Fig. 4E). The specificity of this correlation was tested using an
inhibitor (SP600125) of the JNK pathway, which abrogated both
c-Jun phosphorylation and activation (Supplementary Fig. 4F).
These results showed that AP-1 activation was required for
TNFa-induced SDF-1 expression (Supplementary Fig. 4G), but
not for TGFb expression, suggesting that other pathway controls
TNFa-induced TGFb expression. However, we confirmed that
TGFb expression in ALSCs was completely dependent on
TNFa released by fibroblasts, as it could be prevented using a
neutralizing anti-TNFa antibody (Fig. 4c).
These results suggest that activated fibroblasts (AFs) release
TNFa, which as a paracrine signal induces TGFb autocrine loop
that enhances SDF-1 production in ALSCs.
p38a regulates LSCs and fibroblasts activation. As a well-
known regulator of cytokine production, the role of p38a in the
cross-talk between LSCs and the stromal fibroblasts was investi-
gated using two different approaches. p38a signalling was
inhibited in LSCs using a shRNA (SH3) against this kinase8.
LSC-SH3 cells express very low levels of p38a protein and did not
activate the p38a pathway (Supplementary Fig. 4H). Unlike
ALSCs, cells lacking p38a (ALSC-SH3) did not respond to
fibroblasts stimulation by either releasing SDF-1 protein (Fig. 4d)
or expressing SDF-1 mRNA (Supplementary Fig. 4I). In addition,
recombinant TNFa failed to induce TGFb expression in LSC-SH3
cells (Supplementary Fig. 4J), suggesting that in ALSCs p38a is
essential to activate the TGFb autocrine loop induced by
paracrine TNFa. Furthermore, the direct role of p38a in SDF-1
expression induced by autocrine TGFb was confirmed, as
exogenous TGFb was insufficient to promote SDF-1 mRNA
expression in LSC-SH3 cells (Fig. 4e). The activation of the TGFb
canonical Smad pathway is not affected in LSC-SH3 cells
(Supplementary Fig. 4K).
In fibroblasts, the p38a pathway was inhibited using over-
expression of a dominant negative form of p38 (p38DN)22. p38
activity, but not cJun, was induced in fibroblasts after 6 h of
co-culture, and, as expected, it was absent in p38DN fibroblasts
(Fib.-DN) (Fig. 4f). Moreover, fibroblasts lacking p38a signalling
had reduced levels of both TNFa protein and mRNA compared
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with WT fibroblasts (Supplementary Fig. 4L). Consequently,
when co-cultured with LSCs, p38DN fibroblasts (AF-DN) failed to
secrete TNFa (Fig. 4g, h and Supplementary Fig. 4M).
The role of p38a in TNFa production by fibroblasts was found
to be essential for the cross-talk with stem cells, as AF-DN cells
were unable to induce TGFb expression in ALSCs, but expression
could be restored by supplementing the media with exogenous
TNFa (Fig. 4i).
Consequently, disruption of this cross-talk by p38DN over-
expression, resulted in the loss of SDF-1 expression mediated by
autocrine TGFb signalling in ALSCs, which was rescued by
addition of recombinant TGFb (Fig. 4j). Finally, TNFa-induced
paracrine SDF-1 expression in ALSCs could be inhibited by an
anti-TNFa antibody that neutralized the TNFa secreted by AFs
(Supplementary Fig. 4N).
Together, these findings show a key role for p38a in mediating
TGFb activation and SDF-1 production in ALSCs, and the
expression and release of TNFa by activated fibroblasts.
Finally, we confirmed this essential role in vivo, as LSCs
deficient in p38a signalling (LSC-SH3) are unable to engraft
under the kidney capsule of nude mice. Surprisingly, SDF-1
overexpression could not restore kidney engrafting potential in
p38a-deficient cells (Fig. 4k and Supplementary Table 4). This
could be explained because of the central role of p38a in LSCs
differentiation, and not only in stromal cell recruitment, as we
have previously shown8.
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Figure 4 | Paracrine cross-talk between LSCs and fibroblasts includes SDF-1 expression in ALSCs and fibroblast activation mediated by p38a.
(a) TGFb promotes SDF-1 mRNA expression in LSCs. (b) Fibroblasts induced TGFb expression in ALSCs. (c) TGFb mRNA expression in ALSCs triggers
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overexpressing SDF-1 are not able to engraft in the kidney capsule.
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TNFa triggers ALSCs-mediated fibroblast recruitment. As stem
cell-induced p38a activation was necessary for fibroblast activa-
tion and release of paracrine signals (that is, TNFa), subsequent
functional consequences and cellular responses were investigated.
In addition to cytokine expression, activation of fibroblasts by
ALSCs included induction of migration. As expected, CM from
ALSCs induced the migration of fibroblasts more strongly than
CM from LSCs either cultured alone or co-cultured with p38DN
fibroblasts (Fig. 5a). Migration was independent of proliferation,
which was not affected (Fig. 5b). Thus, the migratory response
was shown to require previous fibroblastic activation of p38a and
TNFa production. In addition, the capacity of CM from ALSCs to
promote fibroblast migration was reduced when TNFa from
fibroblasts was neutralized with a blocking antibody (Fig. 5c).
This was also independent of changes in fibroblast survival
(Fig. 5d). Consequently, disruption of the cross-talk between
fibroblasts and stem cells by blocking TNFa in lung explants
cause the LSCs and fibroblasts to migrate away (Fig. 5e).
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The effect from TNFa blocking is consistent with the previously
shown decrease in SDF-1 levels in ALSCs under this condition
(Supplementary Fig. 4M).
Together, these data suggest that activation of LSCs by
paracrine TNFa is essential for the subsequent ability of ALSCs
to recruit fibroblasts.
Sequential fibroblast activation and EC migration led by LSCs.
Previous studies have suggested that stem cells can have the
potential to cross-talk with vascular cells9. After showing the
paracrine activation of fibroblasts by LSCs and taking into
account the results from kidney engraftments, the potential direct
recruitment of endothelial cells (EC) by ALSCs was investigated.
Surprisingly and unlike fibroblasts, ALSCs fail to recruit
endothelial cells in lung explants and to migrate in vitro
(Fig. 6a and Supplementary Fig. 5A).
Interestingly, increased expression and release of the angio-
genic factors IL8 and VEGF in AFs was observed (Fig. 4g, Fig. 6b
and Supplementary Fig. 5B), suggesting a putative role of these
molecules in endothelial cell recruitment. This expression was
independent of p38a activity, as Fib.-DN also showed increased
expression of angiogenic factors (Fig. 4g and Supplementary
Fig. 5C) and responded to ALSC induction (Fig. 4g and
Supplementary Fig. 5D).
Inhibition of p38a activity may result in a constitutive
activation of the JNK pathway7. Indeed, Fib.-DN had a
constitutively activated JNK/AP-1 pathway, which was also
present in AFs following 12 h of co-culture (Supplementary
Fig. 5E). AP-1 has been shown to regulate the expression of both
VEGF and IL8 (refs 23–26). The direct role of AP-1 was
confirmed, as inhibition of JNK activity by a small molecule
inhibitor (SP600125) prevented the induction of both IL8 and
VEGF expression in AFs by ALSCs (Supplementary Fig. 5F).
Consequently, CM from AFs, Fib.-DN or AF-DN, induced
a higher migration of endothelial cells than CM from
WT fibroblasts (Fig. 6c), independently of proliferation
(Supplementary Fig. 5G). Importantly and consistent with the
above results, only AFs (Fig. 6d and Supplementary Fig. 5H) but
not regular fibroblasts (Fig. 6e and Supplementary Fig. 5I) were
able to recruit endothelial cells in lung explants.
Therefore, endothelial migration and recruitment is mediated
by angiogenic signals, induced by the JNK/AP-1 pathway in AFs,
but not by direct paracrine signals from ALSCs.
SDF-1 induces TNFa and angiogenic factors in fibroblasts.
We have shown that there are two signalling pathways (p38a
and JNK/AP-1) activated in fibroblasts only when they are
co-cultured with LSCs, suggesting that those fibroblasts are also
regulated by paracrine factors from LSCs. We hypothesized that
SDF-1 could be the factor responsible to activate both pathways.
To test this hypothesis, either shControl LSCs or LSCs lacking
SDF-1 (LSC-KD) were co-cultured with fibroblasts. We found
that fibroblast activation was dependent on SDF-1. LSCs lacking
SDF-1 did not induce p38a at 6 h (Supplementary Fig. 6A), nor
JNK/AP-1 activation at 12 h (Supplementary Fig. 6B), correlating
with the reduced expression of TNFa and angiogenic factors (IL8,
VEGF), respectively (Supplementary Fig. 6C,D). However, acti-
vation of both pathways and expression of those cytokines could
be rescued by addition of recombinant SDF-1 (Supplementary
Fig. 6E).
Moreover, we observed that low levels of SDF-1 induced early
expression of TNFa, but only high levels could induce the
expression of VEGF and IL8 in fibroblasts (Supplementary
Fig. 6F). Thus, SDF-1 promoted early activation of p38a, which
correlates with TNFa expression, and later JNK/AP-1 activation
that correlated with IL8 and VEGF expression in AFs.
Interestingly, real-time qPCR analysis showed that TNFa and
VEGF were upregulated in kidney engraftments in comparison
with mouse fibroblasts, giving the former cytokines an in vivo role
in the engrafting and microenvironment process initiated by
LSCs (Supplementary Fig. 6G).
Finally and consistent with the above results, we confirmed
the essential cross-talk between LSCs and fibroblasts to
regulate endothelial cell migration. We found that CM from
fibroblasts co-cultured with SDF-1-deficient stem cells
(AFþ LSC-KD) failed to enhance endothelial migration
(Supplementary Fig. 6H), but it did not affect their proliferation
(Fig. 6i).
Altogether, these findings are consistent with the results from
kidney grafts, in which LSCs lacking SDF-1 failed to recruit
stromal cells as a result of the disruption of the TNFa-TGFb-
p38a-SDF-1 network.
The results allow us to delineate a model that can explain how
lung stem cells promote the formation of their own environment,
a necessary contributor to generating a lung epithelium. LSCs
engage in cross-talk with fibroblasts. Basal levels of SDF-1 from
LSCs can induce both the recruitment and priming of fibroblasts.
‘Low activated’ fibroblasts release TNFa, leading to subsequent
activation of a TGFb/p38a autocrine loop in LSCs (ALSCs) and
further promotion of SDF-1 expression. Higher levels of SDF-1
induce a second and enhanced expression of TNFa (through
p38a) in fibroblasts (AFs). High SDF-1 levels are also able to
induce expression of angiogenic factors (through the JNK/AP-1
pathway) in fibroblasts. IL8 and VEGF released by ‘highly
activated’ fibroblasts then recruit endothelial cells, thus
promoting angiogenesis (Fig. 7f).
Fibroblast-dependent control of stem cell differentiation. We
have begun to identify the paracrine signals required to maintain
a functional cross-talk between stem and stromal cells. Indeed,
this cross-talk is essential because, in kidney engraftments, res-
cued LSC-KD cells by SDF-1 overexpression are able not only to
recruit fibroblasts and endothelial cells to the graft (see Fig. 3c)
but also to differentiate into bronchiolar (Fig. 7a) and alveolar
(Fig. 7b) cells. These results suggest that SDF-1 released by LSCs
is essential to recruit stromal cells and also to allow engraftment
and—consequently—differentiation of LSCs into the kidney
capsule. Why the stromal cells are necessary to develop a LSC
microenvironment is still unknown. We have previously reported
that grafts from single LSCs injections harboured small pools of
Lgr6þ undifferentiated cells, which retain self-renewal ability8.
We hypothesized that stromal cells are required to maintain this
potential.
To test this hypothesis, we injected LSCs and fibroblasts in
human lung explants to allow cell recruitment. After 10 days we
analyzed the expression of several differentiation markers in serial
sections by immunofluorescent microscopy. Consistent with our
hypothesis, now we provided unambiguous evidence that LSCs
located away from fibroblasts are allowed to start lineage
commitment as they engraft into the epithelial tissue differentiat-
ing into AT2 (SPCþ ), Clara (CC10þ ) or AT1 (AQ5þ ) cells
(Fig. 7c, d, and Supplementary Fig. 7A,B). In contrast, LSCs closer
to fibroblasts remain in an undifferentiated state, expressing the
stem cell marker Lgr6 but not the lung differentiation markers
SPC (Surfactant protein C), CC10 (Clara cell 10) or AQ5
(Aquaporin 5) (Fig. 7e).
These findings suggest that LSCs induce the recruitment of
stromal cells to create a functional microenvironment to ensure
self-renewal capacity. Once this capability is ensured, LSCs can
start the differentiation process towards bronchiolar or alveolar
lineage commitment.
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Discussion
Tissue homeostasis is maintained by the integration of a
number of physiological signals derived from cellular and
matrix interactions, and autocrine, paracrine and hormonal
signals. Proper knowledge of the signals and the cell types
involved in the response to physiological and pathological insults
is essential to understand the maintenance of a healthy and
functional organ.
Many reports highlight the connection of the endodermal-
mesenchymal cross-talk and alveolarization during development
of the mouse embryonic lung27–29. In the adult mouse lung, the
role of angiogenic signals in lung alveolarization12 and the role of
lung fibroblasts in lung epithelial differentiation in vitro30 have
also been established. However, a better understanding of the
signals released by specific cell types, the intracellular mediators,
and the balance of their cross-talk is still necessary.
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Here we establish the importance of the paracrine cross-talk
between an enriched LSC population and fibroblasts in the
recruitment of stromal cells and in the posterior maintenance of
the stem cell potential of LSCs. LSCs closer to fibroblasts remain
in an undifferentiated state, ensuring self-renewal capacity. Once
this ability is ensured, LSCs can leave their microenvironment
and respond to differentiation signals leading to lineage
commitment.
In this manuscript, we have revealed the potential of serially
propagated, clonally derived enriched Lgr6þ /E-Cadþ (LSC)
populations to recruit stromal cells, which influence the potential
of LSC to maintain their status (that is, stemness) or differentiate
into mature bronchioalveolar epithelial cell lineages. However,
it is important to note that these serially propagated Lgr6þ /
E-Cadþ cells are heterogeneous. While their ability to generate
bronchioalveolar epithelium when injected under the kidney
capsule, and to differentiate into alveolar or bronchiolar cells in
ex vivo lung explants, is consistent with the enrichment of LSC
activity, it does not prove that the inoculum comprises individual
cells with homogeneous functional attributes. Although the assays
used are considered the best available to test self-renewal and
differentiation potential of human cells, we acknowledge their
limitations. Consequently, although we believe our data are
consistent with the interpretation that Lrg6þ (LSCs) are the key
cells that mediate the cross-talk with fibroblasts, we cannot
exclude the possibility that other Lrg6þ cells with diminished
or no regenerative potential also participate in the cross-talk
with fibroblasts to maintain LSC status in a functional
microenvironment.
We have provided new elements to delineate a functional and
temporal hierarchy, for stem and stromal cell activation in the
human adult lung. In this circuit, LSCs released basal levels of
SDF-1 that moderately activated lung fibroblasts leading to the
production of paracrine signals, and in particular TNFa. This
cytokine in a positive feedback loop activates LSCs (ALSCs),
inducing a TGFb autocrine loop that enhances the expression of
SDF-1. High SDF-1 levels promoted the recruitment and further
activation of fibroblasts (AFs). ALSCs exploited AFs for
endothelial cell recruitment. Only AFs primed by high SDF-1
levels, expressed the angiogenic factors VEGF and IL8, needed for
endothelial chemoattraction.
Intracellularly, the p38aMAPK pathway is key to maintain the
auto-regulation of this circuitry. In fibroblasts, p38a is involved in
responding to SDF-1 and induce cytokine expression, including
TNFa. Lack of p38a MAPK signal resulted in deficient cytokine
release and abrogation of the feedback loop to activate LSCs.
Furthermore, p38a signal in ALSCs mediated TGFb-induced
SDF-1 expression. The secretion of this chemoattractant is
essential for LSCs potential to promote their own niche. This
property of LSCs is crucial to generate a lung-like epithelium
in the kidney capsule, and lack of p38a or SDF-1 avoids
engraftment. In vitro and in vivo rescue by SDF-1 overexpression
or addition of the recombinant protein confirmed that it is
essential in the circuit. The role of p38a guaranteeing the
differentiation potential relies in the previous establishment of a
niche, but this is not sufficient, as shown by overexpression of
SDF-1, which cannot rescue the lack of p38a in promoting LSCs
bronchioalveolar differentiation.
Paracrine cross-talk and activation of stromal fibroblasts are
essential for lung stem cells to initiate and maintain a functional
tissue. Many efforts have been made in the past years trying to
understand the signals controlling lung homeostasis and their
involvement in pathological processes. We have begun to define a
circuitry of intracellular and extracellular components involved in
the setting and maintenance of the system8. We now provide new
targets that include soluble molecules and intracellular pathways
that can be targeted in specific cell types to modify or restore
proper regeneration of the human lung alveolar epithelium, or to
target metastatic lung adenocarcinoma cells.
Methods
Cell culture and isolation of human lung cells. Human umbilical vein
endothelial cells (HUVEC) were purchased from Lonza and cultured in EGM
BulletKitt medium (Lonza, #CC-3124). Fibroblasts, obtained from human lung
tissue, were negatively sorted for CD45 /CD31 /E-Cadherin /Lgr6 to avoid
hematopoietic, endothelial, epithelial and stem cell contamination. Negative sorted
cells were then put in culture in DMEM medium containing 10% fetal bovine
serum (FBS). An aliquot of these cells was fixed, permeabilized and labelled with
antibodies to Vimentin, confirming that 99% of the cells were Vimentinþ .
Human lung stem cells were isolated as describe previously8. Human lung tissue
was obtained from patients undergoing lung resection at Papworth Hospital, UK.
All subjects gave informed consent. Normal lung specimens were finely minced,
resuspended in DMEM containing a mix of collagenase (0.5–3mgml 1,
Whorthington)/dispase (1mgml 1, Invitrogen) and incubated for 30–45min at
37 C in a shaking incubator. The suspension was spin for 5min at 1,200 r.p.m. and
the supernatant removed. The pellet was resuspended in fresh DMEM containing
0.1mgml 1 DNase (optional) and incubated for further 5–10min. The suspension
was washed with PBS, filtered through cell strainers (100 mm and 70mm, BD
Falcon) and treated with red blood cell lysis buffer (Roche Applied Science).
Following further filtration (40 mm mesh) and centrifugation (5min at
1,200 r.p.m.), the isolated cells were cultured in RHB-A medium containing 2%
FCS, with additional insulin (5 mgml 1, Pepro Tech), EGF (10 ngml 1, Pepro
Tech) and FGF2 (20 ngml 1, Pepro Tech) for 2 days. Cells were then sorted in a
flow cytometer. Cells were first negatively sorted for Lyn- (CD45 /CD73 /
CD31 /CD34 /CD33 ) to avoid mesenchymal, hematopoietic and endothelial
cell contamination. Negative sorted cells were then double sorted for
E-Cadherinþ /Lgr6þ and then put in culture or used for in vivo assays. Cells in
culture were maintained in serum-free medium containing EGF and FGF2 (37 C
in a 7% humidified CO2 incubator). All the experiments were performed with lung
stem cells derived from single cell clones as we previously described8. Single cells
were seeded into 96-well plates by limited dilutions and maintained in stem cell
restriction medium RHB-A containing EGF and FGF2. After 14 days, the number
of wells with colonies was counted. Every assay was repeated four times.
Tracking cells in Bleomycin-treated lung explants. Human or adult mouse lungs
were cultured as slices (600–900 mm thickness) and exposed to bleomycin
(5U kg 1 in 100ml PBS) for 2–3 days in vitro. As a control, lung slides were
incubated for 2–3 days in N2B27 medium containing 2–5% FBS. After injury,
EGFP-labelled LSCs, DsRed2-labelled fibroblasts or mCherry-labelled endothelial
cells were microinjected into the lungs and cultured for 7–10 days.
For tracking of LSCs and fibroblasts, EGFP-labelled LSCs (1 106 cells) and
DsRed2-labelled fibroblasts (3 105 cells) were resuspended in 1ml of PBS and
then microinjected (50–100ml) into the lung slides and cultured for 7–10 days in
N2B27 medium containing 2–5% FBS.
For tracking of LSCs and endothelial cells, EGFP-labelled LSCs (3 105 cells)
and mCherry-labelled endothelial cells (3 105 cells) were resuspended in 1ml of
EGM medium (containing 5% FBS) and then microinjected (50–100 ml) into the
lung slides and cultured in the same medium.
For tracking of fibroblasts and endothelial cells, DsRed2-labelled fibroblasts
(activated or non-activated) (3 105 cells) and mCherry-labelled endothelial cells
(3 105 cells) were resuspended in 1ml of EGM medium (containing 5% FBS) and
then microinjected (50–100ml) into the lung slides and cultured in the same
medium.
For cell tracking a Leica Confocal microscope was used. Pictures of selected
regions were taken every day over a period of 7 days. Manual cell tracking was
performed for each cellular type that stayed within the region of analysis with
ImageJ software using the MtrackJ plugin. For live imaging a Leica Confocal
microscope was used. Pictures of selected regions were taken every 20–30min over
a period of 48 h.
For rescue experiments, LSCs knockdown for SDF-1 were co-injected with
recombinant human SDF-1a/CXCL12 (200 ngml 1) (R&D Systems, #350-NS-
010) and matrigel. Alternatively, LSCs knockdown for SDF-1 were transduced with
viruses expressing an shSDF-1 resistant mRNA. For inhibition experiments,
1 mgml 1 of anti-TNFa (R&D Systems, #MAB4101) was added to each well. Lung
slides were fixed for 1–2 h with 4% paraformaldehyde at room temperature. Tissues
were then processed for cryosectioning.
Co-culture assay and preparation of conditioned medium. For co-culture
experiments, cells were cultured at a seeding ratio of 1:3 (LSCs:fibroblasts) in
Boyden chambers (BD Falcon, #353091). A total of 200,000 fibroblasts were seeded
in six-well plates 24 h before the start of the assay. Fibroblasts were then washed
with PBS and 70,000 LSCs were added into each of the upper chambers in
triplicates. Human lung stem cells were co-cultured with fibroblasts in inserts
having a 3.0 mm porous membrane in serum-free DMEM medium. Thus, the
two cell types shared the same culture medium but did not physically contact
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each other. After 48 h of co-culture, the conditioned medium generated by each
cellular type was collected and filtered for its analysis or used it for in vitro assays.
LSCs and fibroblasts were processed for western blotting or quantitative RT–PCR.
For antibody experiments, 1 mgml 1 of anti-TNFa (R&D Systems, #MAB4101) or
anti-TGFb (R&D Systems) was added to each well of the lower or the upper
chamber in triplicates, respectively. For inhibition experiments, fibroblasts were
incubated with 5–10 mM of JNK inhibitor SP600125 (Sigma), and the assay was
allowed to proceed for 24 h.
For rescue experiments, after 24 h of co-culture, recombinant human TGFb1
(10 ngml 1) (Cell Signalling, #8915) or recombinant human TNFa (100 ngml 1)
(Cell Signaling, #8902) was added to the upper chamber and incubated for 6 h or
12 h, respectively.
Cytokine assays. Cytokine Array Panel A (R&D Systems, #ARY006) was used to
determine the cytokines present in the medium of co-cultured LSCs and fibro-
blasts. After 48 h of co-culture, the conditioned medium was transferred to the
array, and the analysis was done according to the manufacturer’s instructions. The
signals were detected and quantified using the Odyssey Infrared Imaging System
(Li-Cor, Biosciences).
Flow cytometry. Single-cell flow cytometry was performed (Fortesa/BD
Biosciences) following fixation and incubation with Muc5AC (1/1,000, Abcam,
ab3649), CGRP (1/1,000, Abcam, ab 81887), SPC (1/500, Santa Cruz, sc-7706),
CC10 (1/1,000, Santa Cruz, sc-25555) and Vimentin (1/1,000, BD Pharmigen,
#550513) primary antibodies, using a BD-Fortessa machine. Secondary antibody
(1/5,000, Alexa Fluor 488 and/or 1/5,000, Alexa Fluor 555, 1/5,000, Alexa Fluor 647
secondary antibodies, Invitrogen) incubation took place for 30min at RT. Data
were processed using FlowJo.
Cellular treatments. To analyse SDF-1 expression, LSCs were treated with
recombinant human TGFb1 (10 ng/ml) (Cell Signaling, #8915) for 6 h or with
recombinant human TNFa (100 ng/ml) (Cell Signaling, #8902) for 12 h. For
western blotting, LSCs were treated with recombinant human TNFa (10 ngml 1)
for 15min. For inhibition experiments, LSCs were pre-incubated with a JNK
inhibitor SP600125 (5–50 mM) 60min before TNFa treatment.
For JNK and p38aMAPK activation, fibroblasts were seeded in six-well plates
24 h before the start of the assay. Then, the medium was changed to DMEM
containing 2% FBS. After 6 h the medium was replaced with DMEM containing
0.5% FBS and recombinant human SDF-1a/CXCL12 (200 ngml 1)
(R&D Systems, #350-NS-010) was added to each well. The same samples were
processed for real-time qPCR to measure TNFa, VEGF and IL8 expression.
Fibroblasts and HUVEC migration assay. The in vitro migration assays were
carried out in Boyden chambers of 8.0 mm porous size (BD Falcon, #353097) using
the protocol described by ref. 31. A total of 100,000 HUVEC cells or fibroblasts
were resuspended in 1ml of 0.2 or 0.5% FBS DMEM medium, respectively. A
0.5ml of the re-suspension was then added into each of the upper chambers in
triplicates. Cells were then stimulated with 0.8–1ml conditioned medium added to
the lower chamber. After 16–20 h of incubation, the non-migrated cells on the
upper side of the chamber membranes were removed. The migrated cells to the
basal side of the chamber membranes were fixed with methanol for 10min at
room temperature. Migrated cells were visualized with DAPI (40 ,6-diamidino-2-
phenylindole) and counted in 5–10 fields per membrane using ImageJ.
For rescue experiments, conditioned medium was supplemented with
recombinant human SDF-1a/CXCL12 (30 ngml 1) (R&D Systems, #350-NS-010).
For fibroblasts recruitment assays that required preincubation with antibodies,
conditioned medium was preincubated with 5 mgml 1 of anti-human
SDF-1/CXCL12 antibody (R&D Systems, #AF-310-NA) or control IgG antibody
for 60min and then added to each well.
Fibroblast and HUVEC proliferation. A total of 30,000 fibroblasts or 25,000
HUVEC cells were seeded in triplicate into 24-well plates 24 h before the start of
the proliferation assay. Fibroblasts or HUVEC cells were then washed with PBS
and 1ml conditioned medium was added to each well. After 48 h, the conditioned
medium was replaced with another 1ml of conditioned medium. Every 24 h, the
cells were trypsinized and counted using a haemocytometer.
shRNA-mediated messenger RNA knockdown. A commercial shRNA (Sigma,
NM_000609.4-247s21c1) was used to knockdown SDF-1/CXCL12 expression:
‘50-CCGGCAAACTGTGCCCTTCAGATTGCTCGAGCAATCTGAAGGGCA
CAGTTTGTTTTTG-30 ’ (underline letters indicate the target region). Lentiviral
particles were produced by co-transfecting 293T cells with pLKO.1-puro, pCMV
D8.9 and VSV-G. Culture supernatants were collected 48 h after transfection and
filtered through 0.45 mM membranes. The supernantans were concentrated by
centrifugation at 28,000 r.p.m. (2 h at 4 C) and resuspended in BSA 1%. LSCs
were then transduced with lentiviruses for 16 h in the presence of 8mgml 1
polybrene (hexadimethrine bromide, Sigma).
Retroviral vector expressing RNAi-resistant SDF-1. A commercial
pBabe-SDF-1a (Addgene, x12270) vector was used to generate an RNAi-resistant
SDF-1. Introducing six silent mutations within shRNA target region generated
the RNAi-resistant SDF-1. The target sequence of SDF-1 mRNA was
50-CAAACTGTGCCCTTCAGATTG-30 , and the target sequence of RNAi-resistant
SDF-1 mRNA was 50-CCA AAT TGC GCG CTG CAA ATA G-30 (bold letters
indicate the silent mutations).
Western blotting. Cells were lysed in lysis buffer (50mM Tris-HCl pH 7.5,
150mM NaCl, 1% (v/v) NP-40, 5mM EDTA pH 8.0, 5mM EGTA pH 8.0, 20mM
NaF, 0.1 mM PMSF, 0.1 mM NaVO3, plus complete protease inhibitor cocktail
(Roche)) and cellular lysates were separated by SDS–PAGE and transferred to
PVDF membranes. The following antibodies were used for protein detection: p38a
MAPK (1/1,000, Cell Signaling, #9228), phospho-p38 (Thr180/Tyr182, 1/1,000,
Cell Signaling, #9215), phospho-c-Jun (Ser63, 1/1,000, Cell Signaling, #9161), c-Jun
(1/1,000, Cell Signaling, #L70B11), phospho-JNK (Thr183/Tyr185, 1/1,000, Cell
Signaling, #9255), JNK (1/1,000, Cell Signalling, #9258), phospho-Smad2
(Ser465/Ser467, 1/1,000, Millipore, #AB3849), Smad2 (1/1,000, Cell Signalling,
#3103), human CXCL12/SDF-1 antibody (1/1,000, R&D Systems, #AF-310-NA),
tubulin (Sigma). For detection, we used Alexa Fluor 680- (1/5,000, Molecular
Probes) or Li-Cor IRDye 800- (Rockland) labelled antibodies with the Odyssey
Infrared Imaging System (Li-Cor).
Total RNA isolation and quantitative RT-PCR. Total RNA was extracted using
Trizol (Invitrogen) and treated with RNase-free DNAse I (Promega). One
microgram RNA was reverse transcribed (Biorad), according to the manufacturer’s
instructions. Quantitative real-time PCR (qPCR) was used to determine the
expression levels of the different genes using specific primer pairs (Eppendorf,
Realplex2) (Supplementary Table 5). Reaction conditions for amplification were as
follows: first step of 95 C 20 s, then 40 cycles of three-step 95 C 3 s, 60 C 30 s and
68 C 20 s with 2 ml of cDNA per reaction in 10ml SYBR Green PCR Master Mix
(Applied Biosystems). Specificity of PCR products was tested by dissociation
curves. Threshold cycles of primer probes were normalized to a housekeeping gene
(GAPDH or b-actin) and relative values calculated.
Kidney capsule engraftments. All mouse experiments were performed according
to UK Home Office Regulations, with the approval of the Ethics Committee at
Cambridge University. CD-1 nude mice (Charles River) were maintained under
standard pathogen-free conditions. Six- to eight-week-old male mice were
anaesthetized with isoflurane (0.5–2%). LSCs WT or LSCs overexpressing a shRNA
to knockdown SDF-1/CXCL12 were disassociated with accutase to generate a
single-cell suspension (0.5–1 105 cells in 10 ml PBS), and this suspension was
injected under the kidney capsule. Mice were killed 2, 3 and 4 weeks later and the
kidneys were collected to examine in vivo differentiation of the injected cells or to
analyse the recruitment of stromal cells. Grafts were removed and prepared for
immunofluorescent microscopy.
For rescue experiments, LSCs overexpressing a shRNA to knockdown
SDF-1/CXCL12 (LSC-KD) were co-injected with recombinant human
SDF-1a/CXCL12 (40–50 ng ml 1) (R&D Systems, #350-NS-010) and matrigel
under the kidney capsule. Alternatively, LSC-KD cells expressing a shSDF-1
resistant mRNA were injected under the renal capsule. Grafts were removed after
2 and 4 weeks and prepared for immunofluorescent microscopy.
Histology and immunostaining. Kidney capsule grafts or lung slides were fixed
with 4% paraformaldehyde and embedded in OCT. Samples were sectioned at
6–12 mm sections. The following primary antibodies were used: anti-human CC10
(1/1,000, Santa Cruz, sc-365992), anti-human SPC (1/1,000, Santa Cruz, sc-7705),
anti-human AQP5 (1/500, Santa Cruz, sc-9890), anti-human LGR6 (1/1,000,
Santa Cruz, SC-48236), anti-human SDF-1 (1/500, Santa Cruz, sc-6193),
anti-human CXCR4 (1/500, Santa Cruz, sc-9046), anti-GFP (1/1,000, Abcam,
ab-13970), anti-RFP (1/1,000, Abcam, ab-62341), anti-CD73 (1/1,000, Abcam,
ab-54217), anti-mouse Vimentin (1/1,000, BD Pharmigen, #550513), anti-human
Nuclei antibody (1/1,000, Millipore, MAB1281). Sections were incubated in
blocking buffer (PBS, 4% donkey serum, 1% Triton) for 1 h at room temperature.
Primary antibodies were incubated overnight at 4 C. Sections were rinsed three
times in PBS and incubated with secondary antibodies diluted at 1:1,000 for 1 h at
room temperature. Slides were mounted in Vectashield mounting media with
DAPI (40 ,6-diamidino-2-phenylindole).
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